TACE shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

TACE shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
TACE shRNA Plasmid (h)

Product Specs
ItemTACE shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-36604-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene NameADAM metallopeptidase domain 17
NCBI Gene AliasesADAM18, CD156B, CSVP, NISBD, NISBD1, TACE

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1OncogeneJanuary 1, 2022Shin DH, Kim SH, Choi M, Bae YK, Han C, Choi BK, Kim SS, Han JY.

(2) β-Cleavage of the prion protein in the human eye: Implications for the spread of infectious prions and human ocular disordersExperimental eye researchNovember 1, 2021Chaudhary S, Ashok A, Wise AS, Rana NA, Kritikos AE, Lindner E, Singh N.

(3) Identification of novel substrates of a disintegrin and metalloprotease 17 by specific labeling of surface proteinsHeliyonDecember 1, 2020Omoteyama K, Sato T, Sato M, Tsutiya A, Arito M, Suematsu N, Kurokawa MS, Kato T.

(4) A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase CβIIThe Journal of biological chemistryMay 15, 2020Yoon J, Cho Y, Kim KY, Yoon MJ, Lee HS, Jeon SD, Cho Y, Kim C, Kim MG.

(5) ADAM-17 is expressed on rheumatoid arthritis fibroblast-like synoviocytes and regulates proinflammatory mediator expression and monocyte adhesionArthritis research & therapyAugust 2, 2018Ishii S, Isozaki T, Furuya H, Takeuchi H, Tsubokura Y, Inagaki K, Kasama T.

(6) iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACEeLifeJune 13, 2018Oikonomidi I, Burbridge E, Cavadas M, Sullivan G, Collis B, Naegele H, Clancy D, Brezinova J, Hu T, Bileck A, et al.

(7) ADAM17 regulates TNF-α expression upon lipopolysaccharide stimulation in oral keratinocytesBiomedical research (Tokyo, Japan)January 1, 2017Hirayama A, Awano S, Seta Y, Ansai T.

(8) Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysatesJournal of CancerJanuary 1, 2017Yoneyama T, Gorry M, Miller MA, Gaither-Davis A, Lin Y, Moss ML, Griffith LG, Lauffenburger DA, Stabile LP, Herman JG, et al.

(9) Nox1 promotes colon cancer cell metastasis via activation of the ADAM17 pathwayEuropean review for medical and pharmacological sciencesNovember 1, 2016Wang HP, Wang X, Gong LF, Chen WJ, Hao Z, Feng SW, Wu YB, Ye T, Cai YK.

(10) ADAM10 mediates the house dust mite-induced release of chemokine ligand CCL20 by airway epitheliumAllergyDecember 1, 2015Post S, Rozeveld D, Jonker MR, Bischoff R, van Oosterhout AJ, Heijink IH.

(11) Taiwan cobra phospholipase A2 suppresses ERK-mediated ADAM17 maturation, thus reducing secreted TNF-α production in human leukemia U937 cellsToxicon : official journal of the International Society on ToxinologyAugust 1, 2014Chen YJ, Lin HC, Chen KC, Lin SR, Cheng TL, Chang LS.

(12) ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCCCancer medicineDecember 1, 2013Kamarajan P, Shin JM, Qian X, Matte B, Zhu JY, Kapila YL.

(13) Human breast cancer-associated fibroblasts enhance cancer cell proliferation through increased TGF-α cleavage by ADAM17Cancer lettersAugust 9, 2013Gao MQ, Kim BG, Kang S, Choi YP, Yoon JH, Cho NH.

(14) Regulation of cigarette smoke-induced mucin expression by neuregulin1β/ErbB3 signalling in human airway epithelial cellsBasic & clinical pharmacology & toxicologyJuly 1, 2011Yu H, Li Q, Kolosov VP, Perelman JM, Zhou X.

(15) Suppression of ADAM17-mediated Lyn/Akt pathways induces apoptosis of human leukemia U937 cells: Bungarus multicinctus protease inhibitor-like protein-1 uncovers the cytotoxic mechanismThe Journal of biological chemistryOctober 1, 2010Liu WH, Chang LS.

(16) Taiwan cobra phospholipase A2 elicits posttranscriptional up-regulation of ADAM17 in human neuroblastoma SK-N-SH cellsJournal of cellular biochemistrySeptember 1, 2010Liu WH, Chen KC, Chiou YL, Lin SR, Chang LS.

(17) Thromboxane prostanoid receptor stimulation induces shedding of the transmembrane chemokine CX3CL1 yet enhances CX3CL1-dependent leukocyte adhesionAmerican journal of physiology. Cell physiologyJune 1, 2010Tole S, Durkan AM, Huang YW, Liu GY, Leung A, Jones LL, Taylor JA, Robinson LA.

(18) Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the boneMolecular cancer research : MCROctober 1, 2009Gilmore JL, Gonterman RM, Menon K, Lorch G, Riese DJ 2nd, Robling A, Foley J.

(19) ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activationCancer biology & therapyJune 1, 2009Zheng X, Jiang F, Katakowski M, Zhang ZG, Lu QE, Chopp M.

(20) Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasivenessCancer scienceMay 1, 2007Zheng X, Jiang F, Katakowski M, Kalkanis SN, Hong X, Zhang X, Zhang ZG, Yang H, Chopp M.

Be the First to Write a Review!